ALBANY MOLECULAR RESEARCH INC Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALBANY MOLECULAR RESEARCH INC for March 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.53 | 3,500 | 64,855 | 27,700 | 31.2 K to 27.7 K (-11.22 %) |
Mar 16 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.79 | 441 | 8,286 | 31,200 | 31.6 K to 31.2 K (-1.39 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | M | 11.85 | 5,000 | 59,250 | 0 | |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Sell | S | 18.26 | 5,000 | 91,300 | 39,495 | 44.5 K to 39.5 K (-11.24 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Buy | M | 11.85 | 5,000 | 59,250 | 44,495 | 39.5 K to 44.5 K (+12.66 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 11.85 | 5,000 | 59,250 | 0 | |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Sell | S | 18.22 | 5,000 | 91,100 | 42,849 | 47.8 K to 42.8 K (-10.45 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 11.85 | 5,000 | 59,250 | 47,849 | 42.8 K to 47.8 K (+11.67 %) |
Mar 12 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.30 | 721 | 13,194 | 31,641 | 32.4 K to 31.6 K (-2.23 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 17.65 | 20,000 | 353,000 | 2,475,818 | 2.5 M to 2.5 M (-0.80 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 17.65 | 20,000 | 353,000 | 2,627,684 | 2.6 M to 2.6 M (-0.76 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Buy | P | 17.72 | 10,000 | 177,200 | 70,673 | 60.7 K to 70.7 K (+16.48 %) |
Mar 10 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 0.00 | 259 | 0 | 32,362 | 32.6 K to 32.4 K (-0.79 %) |
Mar 06 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | P | 17.70 | 20,000 | 354,000 | 414,847 | 394.8 K to 414.8 K (+5.07 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 13.84 | 940 | 13,010 | 394,847 | 393.9 K to 394.8 K (+0.24 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 17.05 | 58,651 | 1,000,000 | 393,907 | 335.3 K to 393.9 K (+17.49 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 17.05 | 2,639 | 44,995 | 33,513 | 30.9 K to 33.5 K (+8.55 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 17.05 | 2,639 | 44,995 | 39,495 | 36.9 K to 39.5 K (+7.16 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Grant | A | 17.05 | 2,639 | 44,995 | 37,741 | 35.1 K to 37.7 K (+7.52 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Grant | A | 17.05 | 2,639 | 44,995 | 31,316 | 28.7 K to 31.3 K (+9.20 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 17.05 | 2,639 | 44,995 | 42,849 | 40.2 K to 42.8 K (+6.56 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Option Exercise | A | 17.05 | 19,078 | 325,280 | 19,078 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Grant | A | 17.05 | 8,824 | 150,449 | 60,673 | 51.8 K to 60.7 K (+17.02 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP & Treasurer | Option Exercise | A | 17.05 | 19,078 | 325,280 | 19,078 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP & Treasurer | Grant | A | 17.05 | 8,824 | 150,449 | 33,824 | 25 K to 33.8 K (+35.30 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | A | 17.05 | 16,280 | 277,574 | 16,280 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 17.05 | 7,530 | 128,387 | 32,621 | 25.1 K to 32.6 K (+30.01 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Option Exercise | A | 17.05 | 22,893 | 390,326 | 22,893 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Grant | A | 17.05 | 10,588 | 180,525 | 46,134 | 35.5 K to 46.1 K (+29.79 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Grant | A | 17.05 | 2,639 | 44,995 | 2,647,684 | 2.6 M to 2.6 M (+0.10 %) |
Mar 03 2015 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.39 | 30,000 | 491,736 | 3,970,983 | 4 M to 4 M (-0.75 %) |